Kventiax SR 150 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

kventiax sr 150 mg tablete s produljenim oslobađanjem

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - kvetiapinfumarat - tableta s produljenim oslobađanjem - 150 mg - urbroj: svaka tableta s produljenim oslobađanjem sadrži 150 mg kvetiapina u obliku kvetiapinfumarata

Vaxneuvance Europska Unija - hrvatski - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumococcal infekcije - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pogledajte odjeljke 4. 4 i 5. 1 za informacije o zaštiti od specifičnih pneumokoknih serotipova. the use of vaxneuvance should be in accordance with official recommendations.